CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
Cannabis Bioscience International Holdings, Inc.
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026
- Market cap
- $2.33M
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Feb 28, 2026
Total debt
$264.09K
$14.59K due within a year
Net debt
$264.00K
After $90 of cash
Implied interest rate
52.36%
FY2025 interest ÷ average debt
Interest coverage
-3.1×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Cannabis Bioscience International's annual report. Trading prices and yields need FINRA TRACE data.